|
Sharpe, A H; Jaenisch, R (1993) Retroviral spongiform degenerative disease produced by the murine neurotropic retrovirus Cas-Br-E. Dev Biol Stand 80:45-52
|
|
Kobayashi, H; Man, S; Graham, C H et al. (1993) Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A 90:3294-8
|
|
Daley, G Q; Van Etten, R A; Baltimore, D (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824-30
|
|
Teicher, B A; Herman, T S; Holden, S A et al. (1990) Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. Science 247:1457-61
|
|
Van Etten, R A; Jackson, P; Baltimore, D (1989) The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669-78
|
|
Stuhlmann, H; Jaenisch, R; Mulligan, R C (1989) Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance. Mol Cell Biol 9:100-8
|
|
Stuhlmann, H; Jaenisch, R; Mulligan, R C (1989) Transfer of a mutant dihydrofolate reductase gene into pre- and postimplantation mouse embryos by a replication-competent retrovirus vector. J Virol 63:4857-65
|
|
Yang, X M; Martinez, R; Le Beau, J et al. (1989) Evolutionary expression of the neuronal form of the src protein in the brain. Proc Natl Acad Sci U S A 86:4751-5
|
|
Jackson, P; Baltimore, D (1989) N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J 8:449-56
|
|
Hartman, S C; Mulligan, R C (1988) Two dominant-acting selectable markers for gene transfer studies in mammalian cells. Proc Natl Acad Sci U S A 85:8047-51
|
Showing the most recent 10 out of 50 publications
